Clinical Trials Directory

Trials / Completed

CompletedNCT04125940

Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Memphis · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study evaluates acute ingestion of the dietary supplement Resync on blood nitrate/nitrite concentrations in a sample of men and women. This will be a crossover trial in which participants take all 4 conditions: 1) 7.5g Resync, 2) 15g Resync, 3) 20g Resync+collagen, 4) placebo.

Detailed description

The product known as Resync contains a blend of nitrate-rich foods including beetroot, red spinach, turmeric, ginger root, and aronia berry extracts. Resync is sold commercially and marketed as an ergogenic aid and/or exercise recovery aid. Manufacturers of Resync recommend users take this product 60-90 minutes before an athletic event or 30-90 minutes after exercise. Resync bases these claims on prior studies investigating the individual ingredients' abilities to increase blood nitrate/nitrite levels; however, there are no clinical trials on the finished product itself. The purpose of this pilot study is to determine the impact of acute, single ingestion of Resync products on blood nitrate/nitrite concentration in a sample of men and women. This will be a crossover trial in which participants take all 4 conditions: 1) 7.5g Resync, 2) 15g Resync, 3) 20g Resync+collagen, 4) placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTResyncThe product known as Resync contains a blend of nitrate-rich foods including beetroot, red spinach, turmeric, ginger root, and aronia berry extracts. Resync is sold commercially and marketed as an ergogenic aid and/or exercise recovery aid.
DIETARY_SUPPLEMENTResync + Collagen17g Collagen + 2g Resync + 1g Carbohydrate
OTHERPlacebo12oz water + food coloring

Timeline

Start date
2019-10-14
Primary completion
2019-12-30
Completion
2019-12-30
First posted
2019-10-14
Last updated
2021-04-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04125940. Inclusion in this directory is not an endorsement.